|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
188,370,000 |
Market
Cap: |
16.70(B) |
Last
Volume: |
1,778,607 |
Avg
Vol: |
1,398,026 |
52
Week Range: |
$76.22 - $99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 811 |
Guru Rank Value : 0.9 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
3,625 |
Total Buy Value |
$0 |
$0 |
$0 |
$314,469 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
156,079 |
229,843 |
273,203 |
611,547 |
Total Sell Value |
$13,472,349 |
$20,340,408 |
$24,241,430 |
$58,103,504 |
Total People Sold |
5 |
5 |
6 |
7 |
Total Sell Transactions |
13 |
19 |
25 |
55 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bienaime Jean Jacques |
Chief Executive Officer |
|
2012-05-16 |
4 |
OE |
$9.86 |
$147,900 |
D/D |
15,000 |
183,691 |
|
- |
|
Lawlis V Bryan |
Director |
|
2012-05-15 |
4/A |
S |
$38.51 |
$342,769 |
D/D |
(8,900) |
10,900 |
|
- |
|
Lawlis V Bryan |
Director |
|
2012-05-15 |
4 |
S |
$38.51 |
$342,769 |
D/D |
(8,900) |
13,400 |
|
- |
|
Lawlis V Bryan |
Director |
|
2012-05-15 |
4 |
OE |
$14.39 |
$92,096 |
D/D |
6,400 |
19,800 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2012-05-15 |
4 |
S |
$38.64 |
$386,373 |
D/D |
(10,000) |
59,030 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2012-05-15 |
4 |
OE |
$17.33 |
$173,300 |
D/D |
10,000 |
69,030 |
|
- |
|
Cooper Jeffrey H |
SVP, Chief Financial Officer |
|
2012-05-14 |
4 |
AS |
$38.09 |
$961,717 |
D/D |
(25,250) |
41,089 |
|
- |
|
Cooper Jeffrey H |
SVP, Chief Financial Officer |
|
2012-05-14 |
4 |
OE |
$14.39 |
$591,128 |
D/D |
25,250 |
66,339 |
|
- |
|
Bienaime Jean Jacques |
Chief Executive Officer |
|
2012-05-14 |
4 |
S |
$38.13 |
$571,893 |
D/D |
(15,000) |
168,691 |
|
- |
|
Bienaime Jean Jacques |
Chief Executive Officer |
|
2012-05-14 |
4 |
OE |
$9.86 |
$147,900 |
D/D |
15,000 |
183,691 |
|
- |
|
Mueller Brian |
VP, Corporate Controller |
|
2012-05-12 |
5 |
D |
$38.00 |
$21,812 |
D/D |
(574) |
15,036 |
|
- |
|
Bienaime Jean Jacques |
Chief Business Officer |
|
2012-05-12 |
5 |
D |
$38.00 |
$297,160 |
D/D |
(7,820) |
149,446 |
|
- |
|
Davis George Eric |
SVP, Chief Commercial Of |
|
2012-05-12 |
5 |
D |
$38.00 |
$29,298 |
D/D |
(771) |
46,200 |
|
- |
|
Fuchs Henry J |
EVP, Chief Medical Officer |
|
2012-05-12 |
5 |
D |
$0.00 |
$0 |
D/D |
(1,101) |
46,497 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2012-05-12 |
5 |
D |
$38.00 |
$60,382 |
D/D |
(1,589) |
23,116 |
|
- |
|
Mueller Brian |
VP, Corporate Controller |
|
2012-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
15,246 |
|
- |
|
Bienaime Jean Jacques |
Chief Executive Officer |
|
2012-05-11 |
4 |
S |
$38.01 |
$969,656 |
D/D |
(25,500) |
168,691 |
|
- |
|
Bienaime Jean Jacques |
Chief Executive Officer |
|
2012-05-11 |
4 |
OE |
$6.46 |
$212,500 |
D/D |
25,000 |
194,191 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2012-05-11 |
4 |
S |
$37.07 |
$989,348 |
D/D |
(26,160) |
59,030 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2012-05-11 |
4 |
OE |
$14.39 |
$324,480 |
D/D |
21,530 |
68,340 |
|
- |
|
Davis George Eric |
SVP, General Counsel |
|
2012-05-11 |
4 |
S |
$37.07 |
$1,604,029 |
D/D |
(42,309) |
51,322 |
|
- |
|
Davis George Eric |
SVP, General Counsel |
|
2012-05-11 |
4 |
OE |
$14.39 |
$575,600 |
D/D |
40,000 |
91,322 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2012-05-11 |
4 |
AS |
$38.00 |
$92,606 |
D/D |
(2,437) |
31,114 |
|
- |
|
Wood Mark |
VP, Human Resources |
|
2012-05-11 |
4 |
OE |
$26.49 |
$64,556 |
D/D |
2,437 |
33,551 |
|
- |
|
Aselage Steve |
EVP, Chief Business Officer |
|
2012-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
63,685 |
|
- |
|
1303 Records found
|
|
Page 20 of 53 |
|
|